{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:02:50Z","timestamp":1790370170438,"version":"4.1.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015375","name":"Affiliated Hospital of Southwest Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.arr.2026.103376","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:16:56Z","timestamp":1790007416000},"page":"103376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nuclear medicine-based diagnosis and therapeutic strategies for neurodegenerative diseases: Clinical progress"],"prefix":"10.1016","volume":"123","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103376_bib1","first-page":"290","article-title":"Added diagnostic value of SPECT to evaluate bone metastases in breast cancer patients with normal whole body bone scan","volume":"12","author":"Abedi","year":"2021","journal-title":"Casp. J. Intern. Med."},{"key":"10.1016\/j.arr.2026.103376_bib2","first-page":"47","article-title":"From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer's Disease","author":"Agnello","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.arr.2026.103376_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cpet.2025.04.002","article-title":"PET and Cardiac Amyloidosis: Which Possible Role?","volume":"20","author":"Aimo","year":"2025","journal-title":"PET Clin."},{"key":"10.1016\/j.arr.2026.103376_bib4","article-title":"Comparative Analysis of Whole-Body Diffusion-Weighted Imaging and PET\/CT in Metastasis Detection: A Prospective Study","volume":"16","author":"Akdal Dolek","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.arr.2026.103376_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3906\/sag-2008-253","article-title":"Dopamine transporter SPECT imaging in Parkinson\u2019s disease and parkinsonian disorders","volume":"51","author":"Akdemir","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12272-025-01538-0","article-title":"PET tracer development for imaging \u03b1-synucleinopathies","volume":"48","author":"Alam","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.arr.2026.103376_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.23736\/S1824-4785.25.03649-0","article-title":"[18F]FDG PET\/CT of FUO\/IUO in special populations","volume":"69","author":"Albano","year":"2025","journal-title":"Q J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0256-4947.75771","article-title":"18F-FDG PET\/CT imaging in oncology","volume":"31","author":"Almuhaideb","year":"2011","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.arr.2026.103376_bib9","first-page":"170","volume":"17","author":"An","year":"2025","journal-title":"Benchmark AI-Based Diagn. Potential. Plasma Proteom. Neurodegener. Dis."},{"key":"10.1016\/j.arr.2026.103376_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1608853","article-title":"Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications","volume":"12","author":"Anjum","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.arr.2026.103376_bib11","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","author":"Anon","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib12","first-page":"3615","article-title":"[Expert consensus on the application of amyloid-PET imaging in the diagnosis of Alzheimer's disease]","volume":"103","author":"Anon","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.arr.2026.103376_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00259-018-4238-2","article-title":"Dual-phase [18F]florbetapir in frontotemporal dementia","volume":"46","author":"Asghar","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cpet.2021.06.008","article-title":"Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development:: In Silico Smart Molecular Design","volume":"16","author":"Ataeinia","year":"2021","journal-title":"PET Clin."},{"key":"10.1016\/j.arr.2026.103376_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biochi.2024.05.005","article-title":"Potential of TSPO radioligands: Bridging brain tumor diagnostics to the peripheries","volume":"224","author":"Avry","year":"2024","journal-title":"Biochimie"},{"key":"10.1016\/j.arr.2026.103376_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116456","article-title":"Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach","volume":"208","author":"Bachli","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2026.103376_bib17","first-page":"15","article-title":"Correlation and Interchangeability of Amyloid, Tau, and Glucose Metabolism PET in Mild Cognitive Impairment and Alzheimer: A Review","author":"Balot","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2026.103376_bib18","first-page":"245","article-title":"Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier","author":"Barker","year":"2024","journal-title":"Sci. Transl. Med. 16 eadi2"},{"key":"10.1016\/j.arr.2026.103376_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103376_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103376_bib21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.120.259192","article-title":"Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results","volume":"63","author":"Baum","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1380561","article-title":"SV2A PET imaging in human neurodegenerative diseases","volume":"16","author":"Bavarsad","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib23","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2967\/jnumed.124.267482","article-title":"Development of a (213)Bi-Labeled Pyridyl Benzofuran for Targeted \u03b1-Therapy of Amyloid-\u03b2 Aggregates","volume":"65","author":"Bender","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14482","article-title":"Plasma p-tau(217) and neurofilament\/p-tau(217) ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration","volume":"21","author":"Benussi","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib25","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.1021\/ja903685b","article-title":"Radioactivity-synchronized fluorescence enhancement using a radionuclide fluorescence-quenched dye","volume":"131","author":"Berezin","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.arr.2026.103376_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cells14161272","article-title":"Current Status of \u03b1-Synuclein Biomarkers and the Need for \u03b1-Synuclein PET Tracers","volume":"14","author":"Berman","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103376_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13195-021-00880-x","article-title":"Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals","volume":"13","author":"Biel","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103376_bib28","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2967\/jnumed.123.265930","article-title":"Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [(18)F]PI-2620","volume":"65","author":"Bischof","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib29","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00259-020-05156-4","article-title":"Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework","volume":"48","author":"Bischof","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib30","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103376_bib31","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1007\/s00259-024-07063-4","article-title":"Early-phase (18)F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer's disease: a comparison with (18)F-FDG-PET and early-phase amyloid-PET","volume":"52","author":"Boccalini","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/alz.13355","article-title":"The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline","volume":"20","author":"Boccalini","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib33","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1177\/0271678X17697989","article-title":"Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases","volume":"37","author":"Bonvento","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2026.103376_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12987-025-00693-2","article-title":"High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose","volume":"22","author":"Bonvicini","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.arr.2026.103376_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4274\/Mirt.80299","article-title":"Improved Benefit of SPECT\/CT Compared to SPECT Alone for the Accurate Localization of Endocrine and Neuroendocrine Tumors","volume":"21","author":"Bural","year":"2012","journal-title":"Mol. Imaging Radionucl. Ther."},{"key":"10.1016\/j.arr.2026.103376_bib36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2967\/jnumed.123.266463","article-title":"Evaluation of Neurodegenerative Disorders with Amyloid-\u03b2, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls","volume":"65","author":"Burkett","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib37","article-title":"A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles","volume":"6","author":"Burnham","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103376_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","article-title":"PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases","volume":"691","author":"Cai","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2026.103376_bib39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2967\/jnumed.109.063156","article-title":"Cellular dosimetry of (111)In using monte carlo N-particle computer code: comparison with analytic methods and correlation with in vitro cytotoxicity","volume":"51","author":"Cai","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70055","article-title":"MEPs and MRI Motor Band Sign as Potential Complementary Markers of Upper Motor Neuron Involvement in Amyotrophic Lateral Sclerosis","volume":"32","author":"Calvi","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib41","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00702-013-0972-6","article-title":"Gender differences in Parkinson's disease: focus on plasma \u03b1-synuclein","volume":"120","author":"Caranci","year":"2013","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2026.103376_bib42","article-title":"[18F]-florbetaben PET\/CT is sensitive for cardiac AL amyloidosis","volume":"54","author":"Cassano Cassano","year":"2024","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.arr.2026.103376_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0000000000001035","article-title":"Overview of tau PET molecular imaging","volume":"35","author":"Cassinelli Petersen","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jalz.2017.09.009","article-title":"Added value of (18)F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study","volume":"14","author":"Ceccaldi","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib45","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.7150\/thno.39203","article-title":"Integrin \u03b1(v)\u03b2(3)-targeted radionuclide therapy combined with immune checkpoint blockade immunotherapy synergistically enhances anti-tumor efficacy","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103376_bib46","article-title":"Bridging Size and Charge Effects of Mesoporous Silica Nanoparticles for Crossing the Blood-Brain Barrier","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.arr.2026.103376_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40658-025-00724-9","article-title":"A review of state-of-the-art resolution improvement techniques in SPECT imaging","volume":"12","author":"Cheng","year":"2025","journal-title":"EJNMMI Phys."},{"key":"10.1016\/j.arr.2026.103376_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13195-020-00685-4","article-title":"Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer's disease","volume":"12","author":"Cho","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103376_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13139-015-0374-9","article-title":"PET Radioligands for Imaging of Tau Pathology: Current Status","volume":"49","author":"Choe","year":"2015","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14165913","article-title":"Artificial Intelligence in Alzheimer's Disease Diagnosis and Prognosis Using PET-MRI: A Narrative Review of High-Impact Literature Post-Tauvid Approval","volume":"14","author":"Christodoulou","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2026.103376_bib51","article-title":"PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside","volume":"13","author":"Corica","year":"2023","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib52","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1016\/j.cell.2025.11.033","article-title":"The evolving landscape of Alzheimer's disease therapy: From A\u03b2 to tau","volume":"188","author":"Courade","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103376_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095023","article-title":"Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade","volume":"23","author":"Cri\u0219an","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib54","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.semnuclmed.2024.09.007","article-title":"Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis","volume":"54","author":"Cumbers","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib55","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.arr.2026.103376_bib56","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/17474124.2019.1685381","article-title":"177)Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors","volume":"13","author":"Das","year":"2019","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.arr.2026.103376_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"TDP-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"de Boer","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103376_bib58","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jad.2023.07.091","article-title":"The development of Non-Suicidal Self-Injury (NSSI) during adolescence: A systematic review and Bayesian meta-analysis","volume":"339","author":"De Luca","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2026.103376_bib59","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/mds.30231","article-title":"Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach","volume":"40","author":"Dhawan","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103376_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40001-023-01627-0","article-title":"Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation","volume":"29","author":"Dhoundiyal","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.arr.2026.103376_bib61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/mol.114.095430","article-title":"Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding","volume":"87","author":"Dong","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.arr.2026.103376_bib62","series-title":"StatPearls. StatPearls Publishing Copyright \u00a9 2026","article-title":"Anatomy, Head and Neck: Blood Brain Barrier","author":"Dotiwala","year":"2026"},{"key":"10.1016\/j.arr.2026.103376_bib63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jagp.2023.08.017","article-title":"Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry","volume":"32","author":"Ducharme","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2026.103376_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvir.2023.100916","article-title":"Advancements and Future Outlook of PET\/CT-Guided Interventions","volume":"26","author":"Dzaye","year":"2023","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"10.1016\/j.arr.2026.103376_bib66","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/alz.13769","article-title":"Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease","volume":"20","author":"Earnest","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib67","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/s00330-024-11094-8","article-title":"ESR Essentials: staging and restaging with FDG-PET\/CT in oncology-practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging","volume":"35","author":"Ebner","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.arr.2026.103376_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2024.11.074","article-title":"Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy","volume":"378","author":"Ediriweera","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2026.103376_bib69","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/jmri.25711","article-title":"PET\/MRI: Where might it replace PET\/CT?","volume":"46","author":"Ehman","year":"2017","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.tins.2009.06.003","article-title":"Metabolic brain networks in neurodegenerative disorders: a functional imaging approach","volume":"32","author":"Eidelberg","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12974-021-02122-1","article-title":"Neuroprotective effect of mitochondrial translocator protein ligand in a mouse model of tauopathy","volume":"18","author":"Fairley","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2026.103376_bib72","article-title":"[Dementia with Lewy bodies in Sweden: diagnosis, treatment, challenges, and support]","volume":"122","author":"Ferreira","year":"2025","journal-title":"Lakartidningen"},{"key":"10.1016\/j.arr.2026.103376_bib73","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1038\/s41380-023-02188-8","article-title":"Individual regional associations between A\u03b2-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies","volume":"28","author":"Finze","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2026.103376_bib74","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1408-24.2024","article-title":"Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers","volume":"45","author":"Fischer","year":"2025","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib75","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00401-024-02801-2","article-title":"Association of in vivo retention of [(18)f] flortaucipir pet with tau neuropathology in corresponding brain regions","volume":"148","author":"Freiburghaus","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103376_bib77","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/WCO.0000000000001271","article-title":"New knowledge on anti-IgLON5 disease","volume":"37","author":"Gaig","year":"2024","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib78","first-page":"1673","article-title":"Lewy Body Dementia","volume":"30","author":"Galvin","year":"2024","journal-title":"Contin. (Minneap. Minn. )"},{"key":"10.1016\/j.arr.2026.103376_bib79","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.7150\/thno.113070","article-title":"Comparative study of [(18)F]AlF-NOTA-FAPI-RGD and [(18)F]FDG\/[(18)F]AlF-NOTA-FAPI-04 PET\/CT in renal cell carcinoma","volume":"15","author":"Gao","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103376_bib80","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.2147\/IJN.S549893","article-title":"Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics","volume":"20","author":"Gao","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103376_bib81","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14737175.2025.2471556","article-title":"Advances in the early diagnosis of amyotrophic lateral sclerosis","volume":"25","author":"Garc\u00eda-Casanova","year":"2025","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.arr.2026.103376_bib82","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jnen\/nlaa014","article-title":"Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy","volume":"79","author":"Gauthreaux","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126398","article-title":"Dual smart monitoring and predictive non-destructive evaluation: A review of advanced hydrogel and stem cell-based strategies for oral cancer theragnostic applications","volume":"687","author":"Ghahramani","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2026.103376_bib84","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1097\/RLU.0000000000005986","article-title":"The Role of SPECT\/CT in 177 Lu-PSMA-617 Theranostics: Case-based Review of Response and Progression Patterns","volume":"50","author":"Ghodsi","year":"2025","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib85","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1754-9485.13441","article-title":"Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)","volume":"66","author":"Gill","year":"2022","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"10.1016\/j.arr.2026.103376_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1533045","article-title":"TDP-43 as a potential retinal biomarker for neurodegenerative diseases","volume":"19","author":"Glashutter","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cells13030223","article-title":"Dementia with Lewy Bodies: Genomics, Transcriptomics, and Its Future with Data Science","volume":"13","author":"Goddard","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103376_bib88","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib89","article-title":"Tau Imaging: Use and Implementation in New Diagnostic and Therapeutic Paradigms for Alzheimer's Disease","volume":"10","author":"Gogola","year":"2025","journal-title":"Geriatr. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib90","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib91","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.semnuclmed.2022.05.001","article-title":"FDG-PET\/CT for Primary Staging and Detection of Recurrence of Breast Cancer","volume":"52","author":"Groheux","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib92","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","article-title":"Frontotemporal lobar degeneration","volume":"9","author":"Grossman","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.arr.2026.103376_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/cells14120907","article-title":"Development of Positron Emission Tomography Radiotracers for Imaging \u03b1-Synuclein Aggregates","volume":"14","author":"Guo","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103376_bib94","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1021\/acs.molpharmaceut.5c01180","article-title":"Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier","volume":"22","author":"Gustavsson","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2026.103376_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1500911","article-title":"Mechanisms of murine cerebral malaria: Multimodal imaging of altered cerebral metabolism and protein oxidation at hemorrhage sites","volume":"1","author":"Hackett","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2026.103376_bib96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2967\/jnumed.120.244061","article-title":"One-Stop Shop: (18)F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases","volume":"62","author":"Hammes","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2023.103409","article-title":"Distinct and joint effects of low and high levels of A\u03b2 and tau deposition on cortical thickness","volume":"38","author":"Hani Hojjati","year":"2023","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.arr.2026.103376_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Front. Drug. Deliv."},{"key":"10.1016\/j.arr.2026.103376_bib99","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00259-022-06001-6","article-title":"Joint EANM\/SNMMI guideline on radiomics in nuclear medicine: Jointly supported by the EANM Physics Committee and the SNMMI Physics, Instrumentation and Data Sciences Council","volume":"50","author":"Hatt","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib100","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00259-003-1446-0","article-title":"Sequence-specific DNA strand cleavage by 111In-labeled peptide nucleic acids","volume":"31","author":"He","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9186902","article-title":"Positron Emission Tomography Imaging of Macrophages in Atherosclerosis with (18)F-GE-180, a Radiotracer for Translocator Protein (TSPO)","volume":"2018","author":"Hellberg","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib102","article-title":"[(177)Lu]Lu-PSMA-617 (Pluvicto(TM)): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib103","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12880-024-01271-y","article-title":"Kidney dynamic SPECT acquisition on a CZT swiveling-detector ring camera: an in vivo pilot study","volume":"24","author":"Hesse","year":"2024","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib104","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41582-025-01126-2","article-title":"Advances in PET imaging of protein aggregates associated with neurodegenerative disease","volume":"21","author":"Higuchi","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70153","article-title":"Heterogeneous tau deposition patterns in the preclinical stage link to domain-specific cognitive deficits","volume":"21","author":"Hojjati","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib106","article-title":"Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders","author":"Homann","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.arr.2026.103376_bib107","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.3390\/curroncol30080529","article-title":"PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues","volume":"30","author":"Hoshi","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.arr.2026.103376_bib108","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.pneurobio.2011.04.012","article-title":"Biomarkers in frontotemporal lobar degenerations--progress and challenges","volume":"95","author":"Hu","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2026.103376_bib109","article-title":"The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer's disease and tau burden","volume":"21","author":"Huang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib110","article-title":"Updates of nuclear medicine imaging in neurodegenerative disorders","author":"Huang","year":"2025","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.arr.2026.103376_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0000000000000611","article-title":"Simultaneous whole-body time-of-flight 18F-FDG PET\/MRI: a pilot study comparing SUVmax with PET\/CT and assessment of MR image quality","volume":"40","author":"Iagaru","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib112","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib113","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","article-title":"Revised criteria for the diagnosis and staging of Alzheimer's disease","volume":"30","author":"Jack","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103376_bib114","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103376_bib116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12017-025-08871-z","article-title":"A Slower-Progressing TDP-43 rNLS8 Mouse Model for ALS: Implications for Preclinical and Mechanistic Studies","volume":"27","author":"Jagaraj","year":"2025","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.arr.2026.103376_bib117","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5864391","article-title":"PET and SPECT Imaging of ALS: An Educational Review","volume":"2023","author":"Jamali","year":"2023","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib118","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-220851","article-title":"FMRI Complexity Correlates with Tau-PET and Cognitive Decline in Late-Onset and Autosomal Dominant Alzheimer's Disease","volume":"95","author":"Jann","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103376_bib119","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker Changes during 20 Years Preceding Alzheimer's Disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103376_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212380","article-title":"Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases","volume":"25","author":"Jiang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib121","article-title":"Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights","volume":"17","author":"Jovalekic","year":"2024","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib122","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s00259-023-06154-y","article-title":"The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review","volume":"50","author":"Jreige","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib123","article-title":"Head-to-Head Comparison of CZT-SPECT and SPECT\/CT Myocardial Perfusion Imaging: Interobserver and Intraobserver Agreement and Diagnostic Performance","volume":"13","author":"Kalantari","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib124","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and \u03b2-amyloid positron emission tomography imaging in dementia with Lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib125","doi-asserted-by":"crossref","first-page":"8728","DOI":"10.1002\/alz.14326","article-title":"Latent change-on-change between amyloid accumulation and cognitive decline","volume":"20","author":"Klinger","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib126","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11307-022-01779-1","article-title":"Head-to-Head Comparison of Tau-PET Radioligands for Imaging TDP-43 in Post-Mortem ALS Brain","volume":"25","author":"Knight","year":"2023","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.arr.2026.103376_bib127","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jlcr.3712","article-title":"Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples","volume":"62","author":"Kolenc Peitl","year":"2019","journal-title":"J. Label. Comp. Radiopharm."},{"key":"10.1016\/j.arr.2026.103376_bib128","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1007\/s00259-025-07270-7","article-title":"Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study","volume":"52","author":"Kolinger","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib129","article-title":"Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts","volume":"14","author":"Korat","year":"2021","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib130","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.3928\/01477447-20181120-05","article-title":"Bone Scintigraphy: A Review of Technical Aspects and Applications in Orthopedic Surgery","volume":"42","author":"Krumme","year":"2019","journal-title":"Orthopedics"},{"key":"10.1016\/j.arr.2026.103376_bib131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41181-019-0075-2","article-title":"Auger electrons for cancer therapy - a review","volume":"4","author":"Ku","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.arr.2026.103376_bib132","article-title":"Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives","volume":"15","author":"Kubeil","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib133","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1038\/s41467-024-52265-x","article-title":"Cryo-EM structure of Alzheimer's disease tau filaments with PET ligand MK-6240","volume":"15","author":"Kunach","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103376_bib134","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11307-025-02049-6","article-title":"Development of New NanoAlbumin-based Radiotracers: Preclinical Evaluation Of [(68)Ga]Ga-DOTA-nanoHSA Conjugates for Lymphatic Imaging Applications","volume":"27","author":"Kuniyil Kulangara","year":"2025","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.arr.2026.103376_bib135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40658-023-00536-9","article-title":"CT-free quantitative SPECT for automatic evaluation of %thyroid uptake based on deep-learning","volume":"10","author":"Kwon","year":"2023","journal-title":"EJNMMI Phys."},{"key":"10.1016\/j.arr.2026.103376_bib136","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1007\/s00415-024-12312-5","article-title":"A multimodal clinical diagnostic approach using MRI and (18)F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathy","volume":"271","author":"Lavrova","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib137","article-title":"Current Trends and Applications of PET\/MRI Hybrid Imaging in Neurodegenerative Diseases and Normal Aging","volume":"14","author":"Lee","year":"2024","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib138","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.semnuclmed.2019.06.004","article-title":"Novel Target Selection for Nuclear Medicine Studies","volume":"49","author":"Lee","year":"2019","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib139","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PPO.0000000000000105","article-title":"Imaging tumor metabolism using positron emission tomography","volume":"21","author":"Lewis","year":"2015","journal-title":"Cancer J."},{"key":"10.1016\/j.arr.2026.103376_bib141","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/ar.21209","article-title":"Detection of A\u03b2 plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP\/PS1 transgenic mice","volume":"293","author":"Li","year":"2010","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.arr.2026.103376_bib142","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1021\/acs.nanolett.0c04560","article-title":"Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy","volume":"21","author":"Lin","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.arr.2026.103376_bib143","article-title":"Comparison of PET\/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.arr.2026.103376_bib144","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3233\/ADR-230025","article-title":"Antibody-Mediated Clearance of Brain Amyloid-\u03b2: Mechanisms of Action, Effects of Natural and Monoclonal Anti-A\u03b2 Antibodies, and Downstream Effects","volume":"7","author":"Loeffler","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2026.103376_bib145","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.semnuclmed.2021.10.004","article-title":"Digital PET vs Analog PET: Clinical Implications?","volume":"52","author":"L\u00f3pez-Mora","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib146","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11307-021-01646-5","article-title":"Direct Comparison of [(18)F]F-DPA with [(18)F]DPA-714 and [(11)C]PBR28 for Neuroinflammation Imaging in the same Alzheimer's Disease Model Mice and Healthy Controls","volume":"24","author":"L\u00f3pez-Pic\u00f3n","year":"2022","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.arr.2026.103376_bib147","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40035-023-00365-x","article-title":"Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints","volume":"12","author":"Lu","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103376_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1387330","article-title":"Low-dose-rate induces more severe cognitive impairment than high-dose-rate in rats exposed to chronic low-dose \u03b3-radiation","volume":"12","author":"Ma","year":"2024","journal-title":"Front. Public. Health"},{"key":"10.1016\/j.arr.2026.103376_bib149","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14283\/jpad.2024.15","article-title":"Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease","volume":"11","author":"Macedo","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103376_bib150","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae043","article-title":"Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging","volume":"6","author":"Macedo","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103376_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70025","article-title":"Advances in PET Imaging of \u03b17 Nicotinic Receptors: From Radioligand Development to CNS Applications","volume":"136","author":"Magnussen","year":"2025","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2026.103376_bib152","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/brain\/awr361","article-title":"Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features","volume":"135","author":"Mahoney","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib153","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2967\/jnumed.125.270167","article-title":"CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma","volume":"66","author":"Makala","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib154","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jamaneurol.2019.4509","article-title":"Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy","volume":"77","author":"Mantyh","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib155","article-title":"Nuclear Medicine Imaging Biomarkers in Parkinson's Disease: Past, Present, and Future Directions","volume":"13","author":"Martini","year":"2025","journal-title":"Med. Sci. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib156","article-title":"Will PET\/MR Imaging Replace PET\/CT for Pediatric Applications?","volume":"15","author":"Masselli","year":"2025","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib157","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5387\/fms.2023-08","article-title":"Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer's disease","volume":"69","author":"Matsuda","year":"2023","journal-title":"Fukushima J. Med. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib158","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00702-024-02774-2","article-title":"Current trends in basic research on Parkinson's disease: from mitochondria, lysosome to \u03b1-synuclein","volume":"131","author":"Matsui","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2026.103376_bib159","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jalz.2018.12.001","article-title":"Predicting diagnosis and cognition with (18)F-AV-1451 tau PET and structural MRI in Alzheimer's disease","volume":"15","author":"Mattsson","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14789450.2020.1831388","article-title":"The role of synaptic biomarkers in the spectrum of neurodegenerative diseases","volume":"17","author":"Mazzucchi","year":"2020","journal-title":"Expert. Rev. Proteom."},{"key":"10.1016\/j.arr.2026.103376_bib161","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103376_bib162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1148\/radiol.2016151155","article-title":"Comparison of Whole-Body (18)F FDG PET\/MR Imaging and Whole-Body (18)F FDG PET\/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer","volume":"281","author":"Melsaether","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.arr.2026.103376_bib163","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.2967\/jnumed.121.263194","article-title":"18)F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies","volume":"63","author":"Minoshima","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib164","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2214\/AJR.18.19953","article-title":"Neuroendocrine Tumor Therapy: (177)Lu-DOTATATE","volume":"211","author":"Mittra","year":"2018","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.arr.2026.103376_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2021.109954","article-title":"Alternative strategies for the synthesis of [(11)C]ER176 for PET imaging of neuroinflammation","volume":"178","author":"Mixdorf","year":"2021","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.arr.2026.103376_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020290","article-title":"The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET","volume":"13","author":"Mohammadi","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2026.103376_bib167","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/cts.12755","article-title":"US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development","volume":"13","author":"Morant","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib168","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","article-title":"EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0","volume":"47","author":"Morbelli","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib169","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(24)01653-2","article-title":"177)Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial","volume":"404","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103376_bib170","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/j.pain.0000000000002927","article-title":"Evidence of neuroinflammation in fibromyalgia syndrome: a [ 18 F]DPA-714 positron emission tomography study","volume":"164","author":"Mueller","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.arr.2026.103376_bib171","doi-asserted-by":"crossref","first-page":"91s","DOI":"10.2967\/jnumed.116.186825","article-title":"Therapeutic Radiometals Beyond (177)Lu and (90)Y: Production and Application of Promising \u03b1-Particle, \u03b2(-)-Particle, and Auger Electron Emitters","volume":"58","author":"M\u00fcller","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib172","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103376_bib173","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5152\/dir.2014.14008","article-title":"Clinical applications of PET\/MRI: current status and future perspectives","volume":"20","author":"Nensa","year":"2014","journal-title":"Diagn. Interv. Radiol."},{"key":"10.1016\/j.arr.2026.103376_bib174","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/mds.29997","article-title":"Rest Tremor in Parkinson's Disease Is Associated with Ipsilateral Striatal Dopamine Transporter Binding","volume":"39","author":"Niemi","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103376_bib175","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/brain\/awaf303","article-title":"Leveraging machine learning to predict Parkinson's disease using pre-symptomatic proteomics data","volume":"149","author":"Nieves-Rodriguez","year":"2026","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib176","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s13246-023-01258-z","article-title":"Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET\/CT images","volume":"46","author":"Nigam","year":"2023","journal-title":"Phys. Eng. Sci. Med."},{"key":"10.1016\/j.arr.2026.103376_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17213412","article-title":"Radioligand Therapy in Cancer Management: A Global Perspective","volume":"17","author":"Ninatti","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib178","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.semnuclmed.2024.09.005","article-title":"18)F-Fluoride PET\/CT-Updates","volume":"54","author":"Nogueira-Lima","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib179","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","article-title":"Association of A\u03b2 deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [(11)C]UCB-J","volume":"13","author":"O'Dell","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103376_bib180","article-title":"Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions","volume":"15","author":"O'Shea","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib181","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: current status and future directions","volume":"6","author":"Okamura","year":"2018","journal-title":"Clin. Transl. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib182","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214253","article-title":"Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the \u03b1-Synucleinopathy Spectrum","volume":"105","author":"Orso","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103376_bib183","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.nucmedbio.2015.06.010","article-title":"PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide","volume":"42","author":"Ory","year":"2015","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.arr.2026.103376_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70648","article-title":"Recent advances in neuroimaging of Alzheimer's disease and related dementias","volume":"21","author":"Ottoy","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.arr.2026.103376_bib186","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.arr.2026.103376_bib187","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s12035-020-01951-0","article-title":"Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in Dogs","volume":"57","author":"Panek","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103376_bib188","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12350-020-02363-2","article-title":"18)F-flutemetamol positron emission tomography in cardiac amyloidosis","volume":"29","author":"Papathanasiou","year":"2022","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.arr.2026.103376_bib189","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.arr.2026.103376_bib190","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2026.103376_bib191","article-title":"Kinetics of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor","volume":"15","author":"Pardridge","year":"2021","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib192","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s11307-025-02033-0","article-title":"Combining Dopamine Transporter and Amyloid PET Tracer: A Preclinical Study on Dual-Target Imaging","volume":"27","author":"Park","year":"2025","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.arr.2026.103376_bib193","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11914-024-00887-x","article-title":"PET\/CT for the Opportunistic Screening of Osteoporosis and Fractures in Cancer Patients","volume":"22","author":"Park","year":"2024","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.arr.2026.103376_bib194","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1039\/D0CS00384K","article-title":"Radiolabelling of nanomaterials for medical imaging and therapy","volume":"50","author":"Pellico","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.arr.2026.103376_bib195","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","article-title":"Quantification of amyloid PET for future clinical use: a state-of-the-art review","volume":"49","author":"Pemberton","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib196","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2967\/jnumed.121.263301","article-title":"From Concept to Regulatory Drug Approval: Lessons for Theranostics","volume":"63","author":"Perera","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib197","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib198","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1007\/s00259-025-07709-x","article-title":"Spatiotemporal dynamics of tau pathology and neurodegeneration in Medial Temporal Lobe (MTL) subregions across alzheimer's disease progression: A multimodal imaging study using second-generation tracer [(18)F]MK-6240","volume":"53","author":"Piao","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib199","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103376_bib200","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00702-024-02813-y","article-title":"Neuroplasticity in Parkinson's disease","volume":"131","author":"Popescu","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2026.103376_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2022.101441","article-title":"Recent advances in Lewy body dementia: A comprehensive review","volume":"69","author":"Prasad","year":"2023","journal-title":"Dis. Mon."},{"key":"10.1016\/j.arr.2026.103376_bib202","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.crad.2010.03.011","article-title":"Molecular imaging: current status and emerging strategies","volume":"65","author":"Pysz","year":"2010","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.arr.2026.103376_bib203","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mdc3.14055","article-title":"I(123)-FP-CIT (DaTSCAN) SPECT beyond the Most Common Causes of Parkinsonism: A Systematic Review","volume":"11","author":"Quintas","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.arr.2026.103376_bib204","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2967\/jnumed.124.268756","article-title":"Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"66","author":"Rabinovici","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11307-024-01972-4","article-title":"PET Imaging of a Transgenic Tau Rat Model SHR24 with [(18)F]AV1451","volume":"27","author":"Ramakrishnan","year":"2025","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.arr.2026.103376_bib206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.62347\/SOGE3962","article-title":"The role of nuclear medicine in neurodegenerative diseases: a narrative review","volume":"14","author":"Riahi","year":"2025","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.arr.2026.103376_bib207","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.semnuclmed.2022.01.004","article-title":"Recent Developments in SPECT\/CT","volume":"52","author":"Ritt","year":"2022","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib208","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1007\/s00259-026-07934-y","article-title":"Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females","volume":"53","author":"Robinson","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2023.10.001","article-title":"Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-\u03b2 toxicity and network hyperexcitability","volume":"21","author":"Roth","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2026.103376_bib210","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2850","article-title":"Amyloid-\u03b2 PET in Alzheimer's disease: A systematic review and Bayesian meta-analysis","volume":"13","author":"Ruan","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.arr.2026.103376_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112999","article-title":"Radiation-Induced Brain Injury: Age Dependency of Neurocognitive Dysfunction Following Radiotherapy","volume":"15","author":"R\u00fcbe","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arr.2026.103376_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120947","article-title":"Development of a novel radioiodinated compound for amyloid and tau deposition imaging in Alzheimer's disease and tauopathy mouse models","volume":"303","author":"Rui","year":"2024","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2026.103376_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081131","article-title":"Transportation of Single-Domain Antibodies through the Blood-Brain Barrier","volume":"11","author":"Ruiz-L\u00f3pez","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2026.103376_bib214","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29174212","article-title":"TSPO Radioligands for Neuroinflammation: An Overview","volume":"29","author":"Salerno","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2026.103376_bib215","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s00044-018-2178-9","article-title":"Dual targeting agents for A\u03b2 plaque\/P-glycoprotein and A\u03b2 plaque\/nicotinic acetylcholine \u03b14\u03b22* receptors-potential approaches to facilitate A\u03b2 plaque removal in Alzheimer's disease brain","volume":"27","author":"Samra","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.arr.2026.103376_bib216","article-title":"Complementary Structural and Chemical Biology Methods Reveal the Basis for Selective Radioligand Binding to \u03b1-Synuclein in MSA Tissue","author":"Sanchez","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.arr.2026.103376_bib217","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1021\/acschemneuro.4c00493","article-title":"Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential \u03b1-Synuclein PET Radioligand","volume":"15","author":"Saturnino Guarino","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib218","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/jnt4040020","article-title":"Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery","volume":"4","author":"Schwinghamer","year":"2023","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.arr.2026.103376_bib219","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1007\/s00259-019-04426-0","article-title":"Engineered antibodies: new possibilities for brain PET?","volume":"46","author":"Sehlin","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26168072","article-title":"Blueprint of collapse: precision biomarkers, molecular cascades, and the engineered decline of fast-progressing ALS","volume":"26","author":"\u0218erban","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib221","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.arr.2026.103376_bib222","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00401-024-02816-9","article-title":"Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation","volume":"148","author":"Shanaki Bavarsad","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2026.103376_bib223","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112425","article-title":"Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?","volume":"14","author":"Siafaka","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103376_bib224","first-page":"47","article-title":"Evaluation of diffuse lymphadenopathy via various quantitative PET\/CT parameters","volume":"26","author":"Silov","year":"2023","journal-title":"Hell. J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib225","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/awaf037","article-title":"The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients","volume":"148","author":"Silva-Rodr\u00edguez","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib226","first-page":"188","article-title":"[Clinical physiology and classical nuclear medicine]","author":"Simonsen","year":"2026","journal-title":"Ugeskr. Laege"},{"key":"10.1016\/j.arr.2026.103376_bib227","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/brain\/awaa155","article-title":"Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes","volume":"143","author":"Sintini","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib228","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.semradonc.2017.04.006","article-title":"Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction","volume":"27","author":"Smart","year":"2017","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.arr.2026.103376_bib229","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1038\/s41467-023-42305-3","article-title":"The \u03b1-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases","volume":"14","author":"Smith","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103376_bib230","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","article-title":"Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations","volume":"135","author":"Snowden","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib231","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib232","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2967\/jnumed.118.220665","article-title":"Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine","volume":"61","author":"Solnes","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib233","article-title":"Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning","volume":"16","author":"Stankeviciute","year":"2024","journal-title":"Alzheimers Dement. (Amst. )"},{"key":"10.1016\/j.arr.2026.103376_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2022.853475","article-title":"The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers","volume":"2","author":"St\u00e9en","year":"2022","journal-title":"Front. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib235","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071460","article-title":"Exploratory Tau PET\/CT with [11C]PBB3 in Patients with Suspected Alzheimer's Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers","volume":"12","author":"Strobel","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2026.103376_bib236","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"Bmj"},{"key":"10.1016\/j.arr.2026.103376_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114704","article-title":"Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease","volume":"374","author":"Tassan Mazzocco","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib238","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jjco\/hyaa004","article-title":"Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer","volume":"50","author":"Tateishi","year":"2020","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103376_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104681","article-title":"Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease","volume":"108","author":"Thapa","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.arr.2026.103376_bib240","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/s41598-025-34257-z","article-title":"Language biomarker screening using AI: a transdiagnostic approach to the brain","volume":"16","author":"Themistocleous","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103376_bib241","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer's disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103376_bib242","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib243","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102237","article-title":"Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles","volume":"14","author":"Thomsen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103376_bib244","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1039\/D5MD00057B","article-title":"The development of a PET radiotracer for imaging alpha synuclein aggregates in Parkinson's disease","volume":"16","author":"Tian","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.arr.2026.103376_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2026.121984","article-title":"Advanced diffusion MRI tract signatures in Alzheimer's disease, dementia with Lewy bodies, and the FTD\/PPA spectrum","volume":"334","author":"Tian","year":"2026","journal-title":"Neuroimage"},{"key":"10.1016\/j.arr.2026.103376_bib246","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2015.08.059","article-title":"Drug and gene delivery across the blood-brain barrier with focused ultrasound","volume":"219","author":"Timbie","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2026.103376_bib247","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1002\/alz.12898","article-title":"Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia","volume":"19","author":"Toller","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib248","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13113098","article-title":"Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond","volume":"13","author":"Tondo","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2026.103376_bib249","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/alz.13447","article-title":"Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease","volume":"20","author":"Tosun","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib250","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.7150\/thno.27679","article-title":"Dual-Modality ImmunoPET\/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody","volume":"8","author":"Tsai","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103376_bib251","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/jamaneurol.2025.3307","article-title":"Incidence and Prevalence of Frontotemporal Dementia: A Systematic Review and Meta-Analysis","volume":"82","author":"Urso","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2025.107772","article-title":"Tau biomarkers for neurodegenerative diseases: Current state and perspectives","volume":"134","author":"Vacchi","year":"2025","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2026.103376_bib253","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00259-025-07743-9","article-title":"High-resolution [(18)F]MK-6240 PET in Alzheimer's disease","volume":"53","author":"Vanderlinden","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib254","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00259-013-2609-2","article-title":"Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine","volume":"41","author":"Verburg","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib255","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00259-024-07038-5","article-title":"Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standard for PET imaging of brain metastases: version 1.0","volume":"52","author":"Verger","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib256","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.27271","article-title":"The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases","volume":"33","author":"Vermeiren","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103376_bib257","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.124.017377","article-title":"Ischemia-Guided Management Using Cardiac SPECT: Reconciling Real-World Evidence in a Post-ISCHEMIA Trial World","volume":"17","author":"Villines","year":"2024","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib258","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2967\/jnumed.114.141713","article-title":"Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?","volume":"57","author":"Vivash","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib259","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/RLU.0000000000003748","article-title":"Thyroid Metastasis in Whole-Body 18F-FDG PET\/CT Restaging of Small Cell Lung Cancer","volume":"47","author":"Vogel","year":"2022","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib260","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1038\/s41467-025-64540-6","article-title":"Development of [(18)F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology","volume":"16","author":"Vokali","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103376_bib261","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/B978-0-444-53497-2.00045-0","article-title":"Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology","volume":"116","author":"Vucic","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib262","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3233\/JAD-240660","article-title":"Diagnosis of Alzheimer's Disease in Clinical Practice: Time to Incorporate Biomarkers?","volume":"101","author":"Vyhnalek","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103376_bib263","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib264","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.30144","article-title":"Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [(11)C]PBR28 PET","volume":"40","author":"Wallin","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103376_bib265","doi-asserted-by":"crossref","DOI":"10.3390\/cells13201705","article-title":"Chronic Low-Dose-Rate Radiation-Induced Persistent DNA Damage and miRNA\/mRNA Expression Changes in Mouse Hippocampus and Blood","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103376_bib266","article-title":"Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer's disease in clinical and community cohorts","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib267","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00259-022-05999-z","article-title":"PET molecular imaging for pathophysiological visualization in Alzheimer's disease","volume":"50","author":"Wang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib268","article-title":"Role of (18)F-florzolotau PET in diagnostic and therapeutic decision-making for cognitive impairment","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib269","doi-asserted-by":"crossref","first-page":"47869","DOI":"10.1021\/acsami.5c07340","article-title":"Theranostic Potential of [(68)Ga]Ga\/[(177)Lu]Lu-LNC1013: A Dual-Purpose Ligand for Cancer Imaging and Radionuclide Therapy","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.arr.2026.103376_bib270","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1149036","article-title":"On gaps of clinical diagnosis of dementia subtypes: A study of Alzheimer's disease and Lewy body disease","volume":"15","author":"Wei","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib271","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13244-022-01262-z","article-title":"Multi-nuclear magnetic resonance spectroscopy: state of the art and future directions","volume":"13","author":"Wei","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib272","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054367","article-title":"Aducanumab-Hope or Disappointment for Alzheimer's Disease","volume":"24","author":"Wojtunik-Kulesza","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib273","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acschemneuro.4c00319","article-title":"Current Progress and Future Directions in Non-Alzheimer's Disease Tau PET Tracers","volume":"16","author":"Wongso","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib274","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1382183","article-title":"Multimodal Molecular Imaging: Current Status and Future Directions","volume":"2018","author":"Wu","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103376_bib275","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1541779","article-title":"Environmental risk factors, protective factors, and biomarkers for amyotrophic lateral sclerosis: an umbrella review","volume":"17","author":"Wu","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib276","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1596392","article-title":"The burden of Parkinson's disease, 1990-2021: a systematic analysis of the Global Burden of Disease study 2021","volume":"17","author":"Wu","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib277","doi-asserted-by":"crossref","DOI":"10.1002\/alz.71675","article-title":"Development and characterization of a novel TDP-43 positron emission tomography tracer: [(18)F]JNJ-TDP43-1","volume":"22","author":"Xia","year":"2026","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib278","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1016\/j.cell.2023.06.004","article-title":"Development of an \u03b1-synuclein positron emission tomography tracer for imaging synucleinopathies","volume":"186","author":"Xiang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103376_bib279","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-024-00787-9","article-title":"Positron emission tomography tracers for synucleinopathies","volume":"20","author":"Xiang","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103376_bib280","article-title":"A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of (68)Ga-NOTA-PRGD2 and (18)F-FDG PET\/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions","volume":"12","author":"Xie","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.arr.2026.103376_bib281","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/RLU.0000000000005297","article-title":"Efficacy and Safety Evaluation of 177Lu-FAP-2286 in the Treatment of Advanced Lung Cancer","volume":"49","author":"Xie","year":"2024","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib282","article-title":"Recent advances in radionuclide medical imaging techniques","volume":"12","author":"Xu","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.arr.2026.103376_bib283","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/acschemneuro.4c00532","article-title":"Novel Dual-Functional Half-Curcumin Analogues as a Fluorescent and PET Probe for \u03b2-Amyloid Imaging in the Alzheimer's Disease APP\/PS1 Model","volume":"16","author":"Yang","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib284","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/brain\/awab120","article-title":"Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease","volume":"144","author":"Yap","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103376_bib285","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2967\/jnumed.112.118885","article-title":"Influence of TSPO genotype on 11C-PBR28 standardized uptake values","volume":"54","author":"Yoder","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib286","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/RLU.0000000000006024","article-title":"A Head-to-Head Comparison of 18 F-FP-CIT and 18 F-FDOPA PET\/CT in Early Parkinson Disease","volume":"50","author":"Yoo","year":"2025","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103376_bib287","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","article-title":"Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson's disease","volume":"28","author":"Yuan","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103376_bib288","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","article-title":"A systematic review of prevalence and incidence studies of dementia with Lewy bodies","volume":"34","author":"Zaccai","year":"2005","journal-title":"Age Ageing"},{"key":"10.1016\/j.arr.2026.103376_bib289","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the Pathogenesis of Alzheimer's Disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.arr.2026.103376_bib290","article-title":"Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2026.103376_bib291","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s13239-020-00496-6","article-title":"Transcellular Model for Neutral and Charged Nanoparticles Across an In Vitro Blood-Brain Barrier","volume":"11","author":"Zhang","year":"2020","journal-title":"Cardiovasc. Eng. Technol."},{"key":"10.1016\/j.arr.2026.103376_bib292","article-title":"Associations between A\u03b2 deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI-PET imaging","volume":"21","author":"Zhang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103376_bib293","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-02041-6","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.arr.2026.103376_bib294","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s42003-024-06406-z","article-title":"An immobilized antibody-based affinity grid strategy for on-grid purification of target proteins enables high-resolution cryo-EM","volume":"7","author":"Zhao","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.arr.2026.103376_bib295","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer's disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell."},{"key":"10.1016\/j.arr.2026.103376_bib296","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-024-00865-1","article-title":"Plasma fibronectin is a prognostic biomarker of disability in Parkinson's disease: a prospective, multicenter cohort study","volume":"11","author":"Zhu","year":"2025","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.arr.2026.103376_bib297","first-page":"10536","article-title":"CT, MRI, and PET imaging features in cervical cancer staging and lymph node metastasis","volume":"13","author":"Zhu","year":"2021","journal-title":"Am. J. Transl. Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:32:00Z","timestamp":1790368320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":297,"alternative-id":["S1568163726003685"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103376","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear medicine-based diagnosis and therapeutic strategies for neurodegenerative diseases: Clinical progress","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103376"}}